The Integrated Genomics Operation (IGO) enables basic, clinical and translational research projects across the Cancer Center. At the IGO, we implement the MSK mission to cure cancer by providing a broad range of genomic services and expertise to our world-class research scientists. We are a high throughput core facility producing >100TB of data per year across >40 applications including fourth generation of genomics technologies such as single cell and spatial transcriptomics.
The IGO R&D team evaluates new technologies and develops ideas for assays, assesses feasibility and develops protocols.
assist in the design and implementation of experiments to test novel technologies
meticulously record experimental details
evaluate results and troubleshoot assays as the need arises
optimize existing IGO assays
read scientific literature to develop a detailed understanding of your work
work with the production lab to transfer newly validated assays
use the Lab Information Management System (LIMS) and iLab to supervise samples and experiments
Enthusiastic, organized and detail-oriented
Meticulous in note-taking and efficient in handling your time
Able to multitask
Interested in the broad scientific principles behind the assays being developed
Able to work independently as well as collaboratively with team members
Someone who can handle a very fast paced environment and the pressure associated with deadlines
An outstanding communicator with a strong understanding of mathematics and stoichiometry
A Bachelors Degree in a Biological, Chemistry, or Science-related field with undergraduate lab experience and excellent references. A track record of academic quality. Previous molecular biology experience (handling DNA, RNA) preferred.
Internal Number: 2021-49516
About Memorial Sloan-Kettering Cancer Center
As one of the world's premier cancer centers, Memorial Sloan-Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan-Kettering has an impact on cancer treatment and the biomedical research agenda around the world.